Health Care: Drugs

Arqule Inc (ARQL: NASDAQ)

$1.7 n/a | n/a%
05/27/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 11.24M 11.25M 15.91M 36.41M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 11.24M 11.25M 15.91M 36.41M
Selling, General, and Administrative Expenses 9.83M 12.15M 12.84M 13.85M
Research & Development 15.56M 22.27M 27.55M 33.97M
Operating Income before D & A (EBITDA) -14.15M -23.17M -24.48M -11.40M
Depreciation & Amortization 393.00K 1.17M 2.46M 2.38M
Interest Income 101.00K 272.00K 502.00K 445.00K
Other Income - Net 277.00K 642.00K 57.00K 113.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -14.17M -24.53M -27.02M -13.23M
Interest Expense 0.00 35.00K 32.00K 26.00K
Pre-Tax Income -14.17M -24.56M -27.06M -13.26M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -13.77M -23.39M -24.60M -10.87M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -13.77M -23.39M -24.60M -10.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -13.77M -23.39M -24.60M -10.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-13.77M -22.29M -23.95M -10.87M
Preferred Dividends
Net Income Available To Common -13.77M -23.39M -24.60M -10.87M
Basic EPS from Continuing Ops. -0.22 -0.37 -0.39 -0.18
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.22 -0.37 -0.39 -0.18
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.22 -0.37 -0.39 -0.18
Basic Normalized Net Income/Share -0.22 -0.36 -0.38 -0.18
EPS fr Continuing Ops. -0.22 -0.37 -0.39 -0.18
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.22 -0.37 -0.39 -0.18
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.22 -0.37 -0.39 -0.18
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.22 -0.36 -0.38 -0.18
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARQL

Latest ARQL Headlines from TheStreet

More Financial News for ARQL

Press Releases for ARQL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter